Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

SANDOSTATIN LAR DIN 02239323

Status: Marketed
Holder: NOVARTIS PHARMACEUTICALS CANADA INC
Molecule: OCTREOTIDE (OCTREOTIDE ACETATE)
Available to quote

Health Canada record

Active ingredient(s)OCTREOTIDE (OCTREOTIDE ACETATE) 10 MG
Dosage formPowder For Suspension (Sustained-Release
RouteIntramuscular
SchedulePRESCRIPTION
ClassHuman
ATCH01CB02 OCTREOTIDE
Original market date27-Jan-1999
Current status date27-Jan-1999
SourceHealth Canada DPD

Establishment licence of the holder

Novartis Pharmaceuticals Canada Inc — licence 100273, currently licensed, last inspection rating C (2025-01-14).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing OCTREOTIDE (OCTREOTIDE ACETATE)

DINProductCompanyFormStrengthStatus
02509768OCTREOTIDE ACETATE INJECTIONGENERIC MEDICAL PARTNERS INCSolutionOCTREOTIDE (OCTREOTIDE ACETATE) 100 MCGApproved
02509741OCTREOTIDE ACETATE INJECTIONGENERIC MEDICAL PARTNERS INCSolutionOCTREOTIDE (OCTREOTIDE ACETATE) 50 MCGApproved
02509776OCTREOTIDE ACETATE INJECTIONGENERIC MEDICAL PARTNERS INCSolutionOCTREOTIDE (OCTREOTIDE ACETATE) 500 MCGApproved
02248640OCTREOTIDE ACETATE OMEGAOMEGA LABORATORIES LIMITEDSolutionOCTREOTIDE (OCTREOTIDE ACETATE) 100 MCGMarketed
02248639OCTREOTIDE ACETATE OMEGAOMEGA LABORATORIES LIMITEDSolutionOCTREOTIDE (OCTREOTIDE ACETATE) 50 MCGMarketed
02248641OCTREOTIDE ACETATE OMEGAOMEGA LABORATORIES LIMITEDSolutionOCTREOTIDE (OCTREOTIDE ACETATE) 500 MCGMarketed
02248642OCTREOTIDE ACETATE OMEGAOMEGA LABORATORIES LIMITEDSolutionOCTREOTIDE (OCTREOTIDE ACETATE) 200 MCGMarketed
02567784OCTREOTIDE DEPOTSTERIMAX INCPowder For Suspension (Sustained-ReleaseOCTREOTIDE (OCTREOTIDE ACETATE) 20 MGMarketed
02567776OCTREOTIDE DEPOTSTERIMAX INCPowder For Suspension (Sustained-ReleaseOCTREOTIDE (OCTREOTIDE ACETATE) 10 MGMarketed
02567792OCTREOTIDE DEPOTSTERIMAX INCPowder For Suspension (Sustained-ReleaseOCTREOTIDE (OCTREOTIDE ACETATE) 30 MGMarketed
02560291OCTREOTIDE INJECTIONSTERIMAX INCSolutionOCTREOTIDE (OCTREOTIDE ACETATE) 500 MCGMarketed
02560283OCTREOTIDE INJECTIONSTERIMAX INCSolutionOCTREOTIDE (OCTREOTIDE ACETATE) 200 MCGMarketed
02560240OCTREOTIDE INJECTIONSTERIMAX INCSolutionOCTREOTIDE (OCTREOTIDE ACETATE) 100 MCGMarketed
02535920OCTREOTIDE INJECTIONMONT-PHARMA INCSolutionOCTREOTIDE (OCTREOTIDE ACETATE) 500 MCGApproved
02535912OCTREOTIDE INJECTIONMONT-PHARMA INCSolutionOCTREOTIDE (OCTREOTIDE ACETATE) 200 MCGApproved
02535904OCTREOTIDE INJECTIONMONT-PHARMA INCSolutionOCTREOTIDE (OCTREOTIDE ACETATE) 100 MCGApproved
02535890OCTREOTIDE INJECTIONMONT-PHARMA INCSolutionOCTREOTIDE (OCTREOTIDE ACETATE) 50 MCGApproved
00839191SANDOSTATINNOVARTIS PHARMACEUTICALS CANADA INCSolutionOCTREOTIDE (OCTREOTIDE ACETATE) 50 MCGMarketed
02239324SANDOSTATIN LARNOVARTIS PHARMACEUTICALS CANADA INCPowder For Suspension (Sustained-ReleaseOCTREOTIDE (OCTREOTIDE ACETATE) 20 MGMarketed
02239325SANDOSTATIN LARNOVARTIS PHARMACEUTICALS CANADA INCPowder For Suspension (Sustained-ReleaseOCTREOTIDE (OCTREOTIDE ACETATE) 30 MGMarketed
02413191OCPHYLPENDOPHARM DIVISION OF PHARMASCIENCE INCSolutionOCTREOTIDE (OCTREOTIDE ACETATE) 50 MCGCancelled Post Market
02413205OCPHYLPENDOPHARM DIVISION OF PHARMASCIENCE INCSolutionOCTREOTIDE (OCTREOTIDE ACETATE) 100 MCGCancelled Post Market
02413213OCPHYLPENDOPHARM DIVISION OF PHARMASCIENCE INCSolutionOCTREOTIDE (OCTREOTIDE ACETATE) 500 MCGCancelled Post Market
02263173OCTREOTIDE ACETATE INJECTION - 100MCG/MLSANDOZ CANADA INCORPORATEDSolutionOCTREOTIDE (OCTREOTIDE ACETATE) 100 MCGCancelled Pre Market
02263181OCTREOTIDE ACETATE INJECTION - 200MCG/MLSANDOZ CANADA INCORPORATEDSolutionOCTREOTIDE (OCTREOTIDE ACETATE) 200 MCGCancelled Pre Market
02263203OCTREOTIDE ACETATE INJECTION - 500MCG/MLSANDOZ CANADA INCORPORATEDSolutionOCTREOTIDE (OCTREOTIDE ACETATE) 500 MCGCancelled Pre Market
02263165OCTREOTIDE ACETATE INJECTION - 50MCG/MLSANDOZ CANADA INCORPORATEDSolutionOCTREOTIDE (OCTREOTIDE ACETATE) 50 MCGCancelled Pre Market
02503786OCTREOTIDE FOR INJECTABLE SUSPENSIONTEVA CANADA LIMITEDPowder For Suspension (Sustained-Release; KitOCTREOTIDE (OCTREOTIDE ACETATE) 30 MGCancelled Post Market
02503751OCTREOTIDE FOR INJECTABLE SUSPENSIONTEVA CANADA LIMITEDKit; Powder For Suspension (Sustained-ReleaseOCTREOTIDE (OCTREOTIDE ACETATE) 10 MGCancelled Post Market
02503778OCTREOTIDE FOR INJECTABLE SUSPENSIONTEVA CANADA LIMITEDKit; Powder For Suspension (Sustained-ReleaseOCTREOTIDE (OCTREOTIDE ACETATE) 20 MGCancelled Post Market
02299445OCTREOTIDE INJECTIONTEVA CANADA LIMITEDSolutionOCTREOTIDE (OCTREOTIDE ACETATE) 200 MCGCancelled Post Market
02299453OCTREOTIDE INJECTIONTEVA CANADA LIMITEDSolutionOCTREOTIDE (OCTREOTIDE ACETATE) 500 MCGCancelled Post Market
02299429OCTREOTIDE INJECTIONTEVA CANADA LIMITEDSolutionOCTREOTIDE (OCTREOTIDE ACETATE) 50 MCGCancelled Post Market
02299437OCTREOTIDE INJECTIONTEVA CANADA LIMITEDSolutionOCTREOTIDE (OCTREOTIDE ACETATE) 100 MCGCancelled Post Market
02049392SANDOSTATINNOVARTIS PHARMACEUTICALS CANADA INCSolutionOCTREOTIDE (OCTREOTIDE ACETATE) 200 MCGCancelled Post Market
00839213SANDOSTATINNOVARTIS PHARMACEUTICALS CANADA INCSolutionOCTREOTIDE (OCTREOTIDE ACETATE) 500 MCGCancelled Post Market
00839205SANDOSTATINNOVARTIS PHARMACEUTICALS CANADA INCSolutionOCTREOTIDE (OCTREOTIDE ACETATE) 100 MCGCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
31021998-12-23Supplement to a New Drug Submission (SNDS)NEW DOSAGE FORM - MICROSPHERES FOR SUSPENSION
Request a quote for SANDOSTATIN LAR

How to read a Canadian DIN record